Patent Foramen Ovale Management in Cryptogenic Stroke Patients: Real-Life Data Collection

Objectives: Ischemic stroke is still an important cause of morbidity and mortality in our country and in the world despite the developments in its treatment in recent years.Stroke recurrence can be avoided by determining the cause of the stroke and planning an effective treatment.To underline the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification, it is important to define and follow undetected (cryptogenic) strokes.Patent foramen ovale (PFO) plays a role in 40-50% of the etiology of cryptogenic strokes.PASCAL study has been published on the course of action if PFO is detected.In this way, the anatomical features of the PFO as well as the clinical features of the patient are evaluated in terms of which treatment to be decided in the patients.Methods: For this purpose, a retrospective evaluation of 42 patients who presented to our clinic with ischemic stroke/TIA and were later discovered to have PFO was assessed.The risk of paradoxical embolism score was determined by asking the patients about their age, smoking status, HT, DM, history of TIA /ischemic stroke, and cortical infarction. ZETAma: skemik inme, son yllarda tedavisinde olan gelimelere ramen lkemizde ve dnyada halen nemli bir morbidite ve mortalite nedenidir.nmenin tekrarn nlemede, inme etiyolojisinin belirlenerek uygun tedavinin planlanmas esastr.TOAST (Trial of ORG 10172 in Acute Stroke Treatment) snflamasnda yer alan nedeni saptanamayan (kriptojenik) inmelerin tanm ve takibi zerinde durulmaldr.Patent foramen ovale (PFO) ise kriptojenik inmelerin etiyolojisinin %40-50 gibi byk bir ksmnda rol oynamaktadr.